nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketamine—CYP2C8—Mometasone—atopic dermatitis	0.0811	0.106	CbGbCtD
Ketamine—PTGS1—Diphenhydramine—atopic dermatitis	0.0808	0.106	CbGbCtD
Ketamine—CYP2B6—Diphenhydramine—atopic dermatitis	0.0615	0.0805	CbGbCtD
Ketamine—CYP2C8—Loratadine—atopic dermatitis	0.0466	0.0609	CbGbCtD
Ketamine—CYP3A4—Pimecrolimus—atopic dermatitis	0.0434	0.0568	CbGbCtD
Ketamine—ABCB1—Tacrolimus—atopic dermatitis	0.0431	0.0564	CbGbCtD
Ketamine—CYP2C9—Loratadine—atopic dermatitis	0.0325	0.0425	CbGbCtD
Ketamine—CYP2C9—Diphenhydramine—atopic dermatitis	0.0325	0.0425	CbGbCtD
Ketamine—ABCB1—Loratadine—atopic dermatitis	0.0315	0.0413	CbGbCtD
Ketamine—ABCB1—Methylprednisolone—atopic dermatitis	0.0289	0.0377	CbGbCtD
Ketamine—CYP2C8—Hydrocortisone—atopic dermatitis	0.0259	0.0339	CbGbCtD
Ketamine—CYP3A4—Tacrolimus—atopic dermatitis	0.0258	0.0338	CbGbCtD
Ketamine—CYP2B6—Dexamethasone—atopic dermatitis	0.0213	0.0278	CbGbCtD
Ketamine—CYP3A4—Loratadine—atopic dermatitis	0.0189	0.0247	CbGbCtD
Ketamine—ABCB1—Betamethasone—atopic dermatitis	0.0188	0.0245	CbGbCtD
Ketamine—ABCB1—Prednisolone—atopic dermatitis	0.0185	0.0242	CbGbCtD
Ketamine—ABCB1—Hydrocortisone—atopic dermatitis	0.0175	0.0229	CbGbCtD
Ketamine—ABCB1—Prednisone—atopic dermatitis	0.0175	0.0229	CbGbCtD
Ketamine—CYP3A4—Methylprednisolone—atopic dermatitis	0.0173	0.0226	CbGbCtD
Ketamine—CYP2C8—Dexamethasone—atopic dermatitis	0.0161	0.0211	CbGbCtD
Ketamine—CYP3A4—Triamcinolone—atopic dermatitis	0.0131	0.0171	CbGbCtD
Ketamine—CYP2C9—Dexamethasone—atopic dermatitis	0.0112	0.0147	CbGbCtD
Ketamine—CYP3A4—Betamethasone—atopic dermatitis	0.0112	0.0147	CbGbCtD
Ketamine—CYP3A4—Prednisolone—atopic dermatitis	0.0111	0.0145	CbGbCtD
Ketamine—ABCB1—Dexamethasone—atopic dermatitis	0.0109	0.0143	CbGbCtD
Ketamine—CYP3A4—Hydrocortisone—atopic dermatitis	0.0105	0.0137	CbGbCtD
Ketamine—CYP3A4—Prednisone—atopic dermatitis	0.0105	0.0137	CbGbCtD
Ketamine—CYP3A4—Dexamethasone—atopic dermatitis	0.00654	0.00855	CbGbCtD
Ketamine—Epilepsy—Hydrocortisone—atopic dermatitis	0.00297	0.024	CcSEcCtD
Ketamine—Salivary hypersecretion—Loratadine—atopic dermatitis	0.00258	0.0208	CcSEcCtD
Ketamine—Epilepsy—Dexamethasone—atopic dermatitis	0.00254	0.0205	CcSEcCtD
Ketamine—Epilepsy—Betamethasone—atopic dermatitis	0.00254	0.0205	CcSEcCtD
Ketamine—Nystagmus—Tacrolimus—atopic dermatitis	0.00254	0.0205	CcSEcCtD
Ketamine—Diplopia—Dimenhydrinate—atopic dermatitis	0.0025	0.0202	CcSEcCtD
Ketamine—Diplopia—Diphenhydramine—atopic dermatitis	0.0025	0.0202	CcSEcCtD
Ketamine—Pulmonary function test decreased—Tacrolimus—atopic dermatitis	0.00241	0.0194	CcSEcCtD
Ketamine—Respiratory depression—Tacrolimus—atopic dermatitis	0.00241	0.0194	CcSEcCtD
Ketamine—Epilepsy—Prednisone—atopic dermatitis	0.00221	0.0179	CcSEcCtD
Ketamine—Erythema—Desonide—atopic dermatitis	0.00206	0.0167	CcSEcCtD
Ketamine—Cystitis noninfective—Tacrolimus—atopic dermatitis	0.00177	0.0143	CcSEcCtD
Ketamine—Cystitis—Tacrolimus—atopic dermatitis	0.00175	0.0141	CcSEcCtD
Ketamine—Diplopia—Fluocinolone Acetonide—atopic dermatitis	0.00173	0.014	CcSEcCtD
Ketamine—Erythema—Fluocinonide—atopic dermatitis	0.00167	0.0135	CcSEcCtD
Ketamine—Bladder pain—Tacrolimus—atopic dermatitis	0.00164	0.0132	CcSEcCtD
Ketamine—Erythema—Pimecrolimus—atopic dermatitis	0.00146	0.0118	CcSEcCtD
Ketamine—Pain—Desonide—atopic dermatitis	0.00144	0.0116	CcSEcCtD
Ketamine—Vision blurred—Diphenhydramine—atopic dermatitis	0.00142	0.0115	CcSEcCtD
Ketamine—Vision blurred—Dimenhydrinate—atopic dermatitis	0.00142	0.0115	CcSEcCtD
Ketamine—Convulsion—Diphenhydramine—atopic dermatitis	0.0013	0.0105	CcSEcCtD
Ketamine—Convulsion—Dimenhydrinate—atopic dermatitis	0.0013	0.0105	CcSEcCtD
Ketamine—Arrhythmia—Loratadine—atopic dermatitis	0.00119	0.00962	CcSEcCtD
Ketamine—Anaphylactic shock—Pimecrolimus—atopic dermatitis	0.00119	0.0096	CcSEcCtD
Ketamine—Anorexia—Diphenhydramine—atopic dermatitis	0.00117	0.00947	CcSEcCtD
Ketamine—Anorexia—Dimenhydrinate—atopic dermatitis	0.00117	0.00947	CcSEcCtD
Ketamine—Pain—Fluocinonide—atopic dermatitis	0.00117	0.00942	CcSEcCtD
Ketamine—Hypotension—Dimenhydrinate—atopic dermatitis	0.00115	0.00928	CcSEcCtD
Ketamine—Hypotension—Diphenhydramine—atopic dermatitis	0.00115	0.00928	CcSEcCtD
Ketamine—Decreased appetite—Dimenhydrinate—atopic dermatitis	0.00107	0.00863	CcSEcCtD
Ketamine—Decreased appetite—Diphenhydramine—atopic dermatitis	0.00107	0.00863	CcSEcCtD
Ketamine—Rash—Desonide—atopic dermatitis	0.00106	0.00857	CcSEcCtD
Ketamine—Dermatitis—Desonide—atopic dermatitis	0.00106	0.00857	CcSEcCtD
Ketamine—Erythema—Fluocinolone Acetonide—atopic dermatitis	0.00104	0.00842	CcSEcCtD
Ketamine—Pain—Pimecrolimus—atopic dermatitis	0.00102	0.00821	CcSEcCtD
Ketamine—Vision blurred—Fluocinolone Acetonide—atopic dermatitis	0.000982	0.00794	CcSEcCtD
Ketamine—Anaphylactic shock—Loratadine—atopic dermatitis	0.000947	0.00765	CcSEcCtD
Ketamine—Shock—Loratadine—atopic dermatitis	0.000931	0.00753	CcSEcCtD
Ketamine—Bradycardia—Tacrolimus—atopic dermatitis	0.000926	0.00749	CcSEcCtD
Ketamine—Hypotension—Loratadine—atopic dermatitis	0.000884	0.00715	CcSEcCtD
Ketamine—Rash—Fluocinonide—atopic dermatitis	0.000859	0.00695	CcSEcCtD
Ketamine—Dermatitis—Fluocinonide—atopic dermatitis	0.000859	0.00694	CcSEcCtD
Ketamine—Arrhythmia—Tacrolimus—atopic dermatitis	0.000813	0.00657	CcSEcCtD
Ketamine—Anaphylactic shock—Mometasone—atopic dermatitis	0.000812	0.00657	CcSEcCtD
Ketamine—Pain—Loratadine—atopic dermatitis	0.000809	0.00654	CcSEcCtD
Ketamine—Erythema—Tacrolimus—atopic dermatitis	0.000792	0.0064	CcSEcCtD
Ketamine—Vomiting—Diphenhydramine—atopic dermatitis	0.000781	0.00632	CcSEcCtD
Ketamine—Vomiting—Dimenhydrinate—atopic dermatitis	0.000781	0.00632	CcSEcCtD
Ketamine—Rash—Dimenhydrinate—atopic dermatitis	0.000775	0.00626	CcSEcCtD
Ketamine—Rash—Diphenhydramine—atopic dermatitis	0.000775	0.00626	CcSEcCtD
Ketamine—Anorexia—Mometasone—atopic dermatitis	0.000774	0.00626	CcSEcCtD
Ketamine—Dermatitis—Dimenhydrinate—atopic dermatitis	0.000774	0.00626	CcSEcCtD
Ketamine—Dermatitis—Diphenhydramine—atopic dermatitis	0.000774	0.00626	CcSEcCtD
Ketamine—Vomiting—Pimecrolimus—atopic dermatitis	0.000756	0.00611	CcSEcCtD
Ketamine—Rash—Pimecrolimus—atopic dermatitis	0.000749	0.00606	CcSEcCtD
Ketamine—Dermatitis—Pimecrolimus—atopic dermatitis	0.000749	0.00605	CcSEcCtD
Ketamine—Vision blurred—Tacrolimus—atopic dermatitis	0.000747	0.00603	CcSEcCtD
Ketamine—Nausea—Dimenhydrinate—atopic dermatitis	0.00073	0.0059	CcSEcCtD
Ketamine—Nausea—Diphenhydramine—atopic dermatitis	0.00073	0.0059	CcSEcCtD
Ketamine—Pain—Fluocinolone Acetonide—atopic dermatitis	0.000727	0.00588	CcSEcCtD
Ketamine—Decreased appetite—Mometasone—atopic dermatitis	0.000706	0.00571	CcSEcCtD
Ketamine—Nausea—Pimecrolimus—atopic dermatitis	0.000706	0.0057	CcSEcCtD
Ketamine—Pain—Mometasone—atopic dermatitis	0.000695	0.00561	CcSEcCtD
Ketamine—Convulsion—Tacrolimus—atopic dermatitis	0.000686	0.00555	CcSEcCtD
Ketamine—Anaphylactic shock—Tacrolimus—atopic dermatitis	0.000647	0.00523	CcSEcCtD
Ketamine—Shock—Tacrolimus—atopic dermatitis	0.000636	0.00514	CcSEcCtD
Ketamine—Anorexia—Tacrolimus—atopic dermatitis	0.000616	0.00498	CcSEcCtD
Ketamine—Hypotension—Tacrolimus—atopic dermatitis	0.000604	0.00488	CcSEcCtD
Ketamine—Vomiting—Loratadine—atopic dermatitis	0.000602	0.00486	CcSEcCtD
Ketamine—Rash—Loratadine—atopic dermatitis	0.000597	0.00482	CcSEcCtD
Ketamine—Dermatitis—Loratadine—atopic dermatitis	0.000596	0.00482	CcSEcCtD
Ketamine—Bradycardia—Prednisolone—atopic dermatitis	0.000592	0.00478	CcSEcCtD
Ketamine—Bradycardia—Hydrocortisone—atopic dermatitis	0.000578	0.00467	CcSEcCtD
Ketamine—Nausea—Loratadine—atopic dermatitis	0.000562	0.00454	CcSEcCtD
Ketamine—Decreased appetite—Tacrolimus—atopic dermatitis	0.000562	0.00454	CcSEcCtD
Ketamine—Pain—Tacrolimus—atopic dermatitis	0.000553	0.00447	CcSEcCtD
Ketamine—Bradycardia—Triamcinolone—atopic dermatitis	0.000544	0.0044	CcSEcCtD
Ketamine—Bradycardia—Methylprednisolone—atopic dermatitis	0.000543	0.00439	CcSEcCtD
Ketamine—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.000541	0.00437	CcSEcCtD
Ketamine—Rash—Fluocinolone Acetonide—atopic dermatitis	0.000536	0.00434	CcSEcCtD
Ketamine—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.000536	0.00433	CcSEcCtD
Ketamine—Arrhythmia—Prednisolone—atopic dermatitis	0.000519	0.0042	CcSEcCtD
Ketamine—Vomiting—Mometasone—atopic dermatitis	0.000516	0.00417	CcSEcCtD
Ketamine—Rash—Mometasone—atopic dermatitis	0.000512	0.00414	CcSEcCtD
Ketamine—Dermatitis—Mometasone—atopic dermatitis	0.000512	0.00414	CcSEcCtD
Ketamine—Arrhythmia—Hydrocortisone—atopic dermatitis	0.000507	0.0041	CcSEcCtD
Ketamine—Erythema—Prednisolone—atopic dermatitis	0.000506	0.00409	CcSEcCtD
Ketamine—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000505	0.00408	CcSEcCtD
Ketamine—Erythema—Hydrocortisone—atopic dermatitis	0.000494	0.00399	CcSEcCtD
Ketamine—Bradycardia—Betamethasone—atopic dermatitis	0.000494	0.00399	CcSEcCtD
Ketamine—Bradycardia—Dexamethasone—atopic dermatitis	0.000494	0.00399	CcSEcCtD
Ketamine—Nausea—Mometasone—atopic dermatitis	0.000482	0.0039	CcSEcCtD
Ketamine—Arrhythmia—Triamcinolone—atopic dermatitis	0.000478	0.00386	CcSEcCtD
Ketamine—Vision blurred—Prednisolone—atopic dermatitis	0.000477	0.00385	CcSEcCtD
Ketamine—Arrhythmia—Methylprednisolone—atopic dermatitis	0.000476	0.00385	CcSEcCtD
Ketamine—Erythema—Triamcinolone—atopic dermatitis	0.000465	0.00376	CcSEcCtD
Ketamine—Erythema—Methylprednisolone—atopic dermatitis	0.000464	0.00375	CcSEcCtD
Ketamine—Convulsion—Prednisolone—atopic dermatitis	0.000438	0.00354	CcSEcCtD
Ketamine—Arrhythmia—Betamethasone—atopic dermatitis	0.000433	0.0035	CcSEcCtD
Ketamine—Arrhythmia—Dexamethasone—atopic dermatitis	0.000433	0.0035	CcSEcCtD
Ketamine—Bradycardia—Prednisone—atopic dermatitis	0.00043	0.00348	CcSEcCtD
Ketamine—Convulsion—Hydrocortisone—atopic dermatitis	0.000428	0.00346	CcSEcCtD
Ketamine—Erythema—Dexamethasone—atopic dermatitis	0.000422	0.00341	CcSEcCtD
Ketamine—Erythema—Betamethasone—atopic dermatitis	0.000422	0.00341	CcSEcCtD
Ketamine—Anaphylactic shock—Prednisolone—atopic dermatitis	0.000413	0.00334	CcSEcCtD
Ketamine—Vomiting—Tacrolimus—atopic dermatitis	0.000411	0.00332	CcSEcCtD
Ketamine—Rash—Tacrolimus—atopic dermatitis	0.000408	0.00329	CcSEcCtD
Ketamine—Dermatitis—Tacrolimus—atopic dermatitis	0.000407	0.00329	CcSEcCtD
Ketamine—Shock—Prednisolone—atopic dermatitis	0.000406	0.00328	CcSEcCtD
Ketamine—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000403	0.00326	CcSEcCtD
Ketamine—Convulsion—Triamcinolone—atopic dermatitis	0.000403	0.00326	CcSEcCtD
Ketamine—Convulsion—Methylprednisolone—atopic dermatitis	0.000402	0.00325	CcSEcCtD
Ketamine—Shock—Hydrocortisone—atopic dermatitis	0.000397	0.00321	CcSEcCtD
Ketamine—Anorexia—Hydrocortisone—atopic dermatitis	0.000384	0.00311	CcSEcCtD
Ketamine—Nausea—Tacrolimus—atopic dermatitis	0.000384	0.0031	CcSEcCtD
Ketamine—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.00038	0.00307	CcSEcCtD
Ketamine—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.000379	0.00306	CcSEcCtD
Ketamine—Arrhythmia—Prednisone—atopic dermatitis	0.000377	0.00305	CcSEcCtD
Ketamine—Hypotension—Hydrocortisone—atopic dermatitis	0.000377	0.00305	CcSEcCtD
Ketamine—Shock—Triamcinolone—atopic dermatitis	0.000374	0.00302	CcSEcCtD
Ketamine—Shock—Methylprednisolone—atopic dermatitis	0.000373	0.00301	CcSEcCtD
Ketamine—Erythema—Prednisone—atopic dermatitis	0.000368	0.00297	CcSEcCtD
Ketamine—Convulsion—Betamethasone—atopic dermatitis	0.000366	0.00296	CcSEcCtD
Ketamine—Convulsion—Dexamethasone—atopic dermatitis	0.000366	0.00296	CcSEcCtD
Ketamine—Hypotension—Methylprednisolone—atopic dermatitis	0.000354	0.00286	CcSEcCtD
Ketamine—Pain—Prednisolone—atopic dermatitis	0.000353	0.00285	CcSEcCtD
Ketamine—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000351	0.00283	CcSEcCtD
Ketamine—Vision blurred—Prednisone—atopic dermatitis	0.000347	0.0028	CcSEcCtD
Ketamine—Pain—Hydrocortisone—atopic dermatitis	0.000345	0.00279	CcSEcCtD
Ketamine—Anaphylactic shock—Dexamethasone—atopic dermatitis	0.000345	0.00278	CcSEcCtD
Ketamine—Anaphylactic shock—Betamethasone—atopic dermatitis	0.000345	0.00278	CcSEcCtD
Ketamine—Shock—Dexamethasone—atopic dermatitis	0.000339	0.00274	CcSEcCtD
Ketamine—Shock—Betamethasone—atopic dermatitis	0.000339	0.00274	CcSEcCtD
Ketamine—Anorexia—Dexamethasone—atopic dermatitis	0.000328	0.00265	CcSEcCtD
Ketamine—Anorexia—Betamethasone—atopic dermatitis	0.000328	0.00265	CcSEcCtD
Ketamine—Pain—Triamcinolone—atopic dermatitis	0.000325	0.00262	CcSEcCtD
Ketamine—Hypotension—Betamethasone—atopic dermatitis	0.000322	0.0026	CcSEcCtD
Ketamine—Hypotension—Dexamethasone—atopic dermatitis	0.000322	0.0026	CcSEcCtD
Ketamine—Convulsion—Prednisone—atopic dermatitis	0.000319	0.00257	CcSEcCtD
Ketamine—Anaphylactic shock—Prednisone—atopic dermatitis	0.0003	0.00243	CcSEcCtD
Ketamine—Decreased appetite—Dexamethasone—atopic dermatitis	0.0003	0.00242	CcSEcCtD
Ketamine—Decreased appetite—Betamethasone—atopic dermatitis	0.0003	0.00242	CcSEcCtD
Ketamine—Shock—Prednisone—atopic dermatitis	0.000295	0.00239	CcSEcCtD
Ketamine—Pain—Dexamethasone—atopic dermatitis	0.000295	0.00238	CcSEcCtD
Ketamine—Pain—Betamethasone—atopic dermatitis	0.000295	0.00238	CcSEcCtD
Ketamine—Anorexia—Prednisone—atopic dermatitis	0.000286	0.00231	CcSEcCtD
Ketamine—Decreased appetite—Prednisone—atopic dermatitis	0.000261	0.00211	CcSEcCtD
Ketamine—Rash—Prednisolone—atopic dermatitis	0.00026	0.0021	CcSEcCtD
Ketamine—Dermatitis—Prednisolone—atopic dermatitis	0.00026	0.0021	CcSEcCtD
Ketamine—Vomiting—Hydrocortisone—atopic dermatitis	0.000256	0.00207	CcSEcCtD
Ketamine—Rash—Hydrocortisone—atopic dermatitis	0.000254	0.00206	CcSEcCtD
Ketamine—Dermatitis—Hydrocortisone—atopic dermatitis	0.000254	0.00205	CcSEcCtD
Ketamine—Nausea—Prednisolone—atopic dermatitis	0.000245	0.00198	CcSEcCtD
Ketamine—Vomiting—Triamcinolone—atopic dermatitis	0.000241	0.00195	CcSEcCtD
Ketamine—Vomiting—Methylprednisolone—atopic dermatitis	0.000241	0.00195	CcSEcCtD
Ketamine—Nausea—Hydrocortisone—atopic dermatitis	0.00024	0.00194	CcSEcCtD
Ketamine—Rash—Triamcinolone—atopic dermatitis	0.000239	0.00194	CcSEcCtD
Ketamine—Dermatitis—Triamcinolone—atopic dermatitis	0.000239	0.00193	CcSEcCtD
Ketamine—Rash—Methylprednisolone—atopic dermatitis	0.000239	0.00193	CcSEcCtD
Ketamine—Dermatitis—Methylprednisolone—atopic dermatitis	0.000239	0.00193	CcSEcCtD
Ketamine—Nausea—Triamcinolone—atopic dermatitis	0.000226	0.00182	CcSEcCtD
Ketamine—Nausea—Methylprednisolone—atopic dermatitis	0.000225	0.00182	CcSEcCtD
Ketamine—Vomiting—Betamethasone—atopic dermatitis	0.000219	0.00177	CcSEcCtD
Ketamine—Vomiting—Dexamethasone—atopic dermatitis	0.000219	0.00177	CcSEcCtD
Ketamine—Rash—Dexamethasone—atopic dermatitis	0.000217	0.00176	CcSEcCtD
Ketamine—Rash—Betamethasone—atopic dermatitis	0.000217	0.00176	CcSEcCtD
Ketamine—Dermatitis—Betamethasone—atopic dermatitis	0.000217	0.00175	CcSEcCtD
Ketamine—Dermatitis—Dexamethasone—atopic dermatitis	0.000217	0.00175	CcSEcCtD
Ketamine—Nausea—Dexamethasone—atopic dermatitis	0.000205	0.00165	CcSEcCtD
Ketamine—Nausea—Betamethasone—atopic dermatitis	0.000205	0.00165	CcSEcCtD
Ketamine—Vomiting—Prednisone—atopic dermatitis	0.000191	0.00154	CcSEcCtD
Ketamine—Rash—Prednisone—atopic dermatitis	0.000189	0.00153	CcSEcCtD
Ketamine—Dermatitis—Prednisone—atopic dermatitis	0.000189	0.00153	CcSEcCtD
Ketamine—Nausea—Prednisone—atopic dermatitis	0.000178	0.00144	CcSEcCtD
Ketamine—DRD2—GPCR ligand binding—CXCR3—atopic dermatitis	7.84e-05	0.000703	CbGpPWpGaD
Ketamine—OPRM1—TCR Signaling Pathway—IL6—atopic dermatitis	7.84e-05	0.000702	CbGpPWpGaD
Ketamine—ABCB1—Allograft Rejection—IFNG—atopic dermatitis	7.82e-05	0.0007	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—CCL27—atopic dermatitis	7.81e-05	0.0007	CbGpPWpGaD
Ketamine—OPRM1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	7.68e-05	0.000688	CbGpPWpGaD
Ketamine—OPRK1—GPCR ligand binding—CCR5—atopic dermatitis	7.67e-05	0.000688	CbGpPWpGaD
Ketamine—OPRK1—G alpha (i) signalling events—CXCL8—atopic dermatitis	7.66e-05	0.000687	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—TAC1—atopic dermatitis	7.66e-05	0.000687	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—NPS—atopic dermatitis	7.66e-05	0.000687	CbGpPWpGaD
Ketamine—DRD2—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	7.53e-05	0.000675	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—CXCR3—atopic dermatitis	7.51e-05	0.000673	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—IL5—atopic dermatitis	7.48e-05	0.00067	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—CCL11—atopic dermatitis	7.45e-05	0.000668	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CCL17—atopic dermatitis	7.37e-05	0.00066	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—FCER2—atopic dermatitis	7.35e-05	0.000658	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—NPS—atopic dermatitis	7.31e-05	0.000655	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—TAC1—atopic dermatitis	7.31e-05	0.000655	CbGpPWpGaD
Ketamine—ABCB1—Allograft Rejection—CXCL8—atopic dermatitis	7.27e-05	0.000651	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CCL27—atopic dermatitis	7.2e-05	0.000646	CbGpPWpGaD
Ketamine—OPRM1—GPCR ligand binding—CCL5—atopic dermatitis	7.2e-05	0.000645	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—CCR3—atopic dermatitis	7.19e-05	0.000644	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—CXCR3—atopic dermatitis	7.17e-05	0.000642	CbGpPWpGaD
Ketamine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	7.16e-05	0.000642	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—IL5—atopic dermatitis	7.12e-05	0.000638	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—TAC1—atopic dermatitis	7.05e-05	0.000632	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—NPS—atopic dermatitis	7.05e-05	0.000632	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—CCL17—atopic dermatitis	7.01e-05	0.000628	CbGpPWpGaD
Ketamine—ABCB1—Allograft Rejection—IL1B—atopic dermatitis	6.97e-05	0.000625	CbGpPWpGaD
Ketamine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	6.95e-05	0.000623	CbGpPWpGaD
Ketamine—ABCB1—Allograft Rejection—IL2—atopic dermatitis	6.95e-05	0.000622	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—CXCR3—atopic dermatitis	6.92e-05	0.00062	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	6.87e-05	0.000616	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	6.84e-05	0.000613	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CCL22—atopic dermatitis	6.83e-05	0.000612	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—IL5—atopic dermatitis	6.79e-05	0.000609	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—CCR3—atopic dermatitis	6.69e-05	0.000599	CbGpPWpGaD
Ketamine—PTGS1—Selenium Micronutrient Network—IL6—atopic dermatitis	6.65e-05	0.000596	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—KIF3A—atopic dermatitis	6.57e-05	0.000589	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—IL5—atopic dermatitis	6.56e-05	0.000588	CbGpPWpGaD
Ketamine—OPRM1—GPCR ligand binding—CCR5—atopic dermatitis	6.49e-05	0.000581	CbGpPWpGaD
Ketamine—OPRM1—G alpha (i) signalling events—CXCL8—atopic dermatitis	6.48e-05	0.00058	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CCL17—atopic dermatitis	6.46e-05	0.000579	CbGpPWpGaD
Ketamine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	6.45e-05	0.000578	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—TAC1—atopic dermatitis	6.41e-05	0.000574	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—NPS—atopic dermatitis	6.41e-05	0.000574	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—CXCL10—atopic dermatitis	6.38e-05	0.000571	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—CXCL10—atopic dermatitis	6.34e-05	0.000568	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—CXCR3—atopic dermatitis	6.28e-05	0.000563	CbGpPWpGaD
Ketamine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	6.09e-05	0.000546	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CCL27—atopic dermatitis	6.09e-05	0.000546	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—CCR3—atopic dermatitis	6.07e-05	0.000544	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—CXCL10—atopic dermatitis	6.07e-05	0.000544	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—TAC1—atopic dermatitis	5.96e-05	0.000534	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—NPS—atopic dermatitis	5.96e-05	0.000534	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—IL5—atopic dermatitis	5.96e-05	0.000534	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CCL11—atopic dermatitis	5.94e-05	0.000532	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CMA1—atopic dermatitis	5.94e-05	0.000532	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—CXCR3—atopic dermatitis	5.85e-05	0.000524	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—CXCL10—atopic dermatitis	5.79e-05	0.000519	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—GLB1—atopic dermatitis	5.79e-05	0.000519	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—KIF3A—atopic dermatitis	5.76e-05	0.000516	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—CCL11—atopic dermatitis	5.65e-05	0.000506	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—CXCL10—atopic dermatitis	5.59e-05	0.000501	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—STAT6—atopic dermatitis	5.59e-05	0.0005	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—FCER2—atopic dermatitis	5.57e-05	0.000499	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—ADSL—atopic dermatitis	5.55e-05	0.000497	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—IL5—atopic dermatitis	5.54e-05	0.000497	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—CCL5—atopic dermatitis	5.49e-05	0.000492	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CCL17—atopic dermatitis	5.46e-05	0.000489	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—CCL5—atopic dermatitis	5.46e-05	0.000489	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—TAC1—atopic dermatitis	5.41e-05	0.000485	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—NPS—atopic dermatitis	5.41e-05	0.000485	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—CXCR3—atopic dermatitis	5.31e-05	0.000476	CbGpPWpGaD
Ketamine—TACR1—GPCR downstream signaling—CXCL8—atopic dermatitis	5.31e-05	0.000476	CbGpPWpGaD
Ketamine—OPRD1—GPCR ligand binding—CXCL8—atopic dermatitis	5.29e-05	0.000474	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—CCL5—atopic dermatitis	5.23e-05	0.000468	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CCL11—atopic dermatitis	5.21e-05	0.000467	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CMA1—atopic dermatitis	5.21e-05	0.000467	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CCL22—atopic dermatitis	5.18e-05	0.000464	CbGpPWpGaD
Ketamine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	5.15e-05	0.000461	CbGpPWpGaD
Ketamine—SLC6A2—Transmembrane transport of small molecules—PPARA—atopic dermatitis	5.13e-05	0.000459	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—CXCL10—atopic dermatitis	5.08e-05	0.000455	CbGpPWpGaD
Ketamine—TACR1—GPCR downstream signaling—IL2—atopic dermatitis	5.07e-05	0.000455	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—CCR3—atopic dermatitis	5.07e-05	0.000454	CbGpPWpGaD
Ketamine—ABCB1—Allograft Rejection—TNF—atopic dermatitis	5.06e-05	0.000453	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—IL5—atopic dermatitis	5.03e-05	0.000451	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	5.03e-05	0.000451	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—CCL5—atopic dermatitis	4.99e-05	0.000447	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—CCR5—atopic dermatitis	4.95e-05	0.000443	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—CCR5—atopic dermatitis	4.92e-05	0.00044	CbGpPWpGaD
Ketamine—DRD2—G alpha (i) signalling events—CXCL8—atopic dermatitis	4.91e-05	0.00044	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—STAT6—atopic dermatitis	4.9e-05	0.000439	CbGpPWpGaD
Ketamine—DRD2—Circadian rythm related genes—MAPK8—atopic dermatitis	4.89e-05	0.000438	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—KIF3A—atopic dermatitis	4.87e-05	0.000436	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CCR3—atopic dermatitis	4.84e-05	0.000434	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—NGF—atopic dermatitis	4.84e-05	0.000434	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—CXCL8—atopic dermatitis	4.82e-05	0.000432	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—CCL5—atopic dermatitis	4.81e-05	0.000431	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—CXCL10—atopic dermatitis	4.73e-05	0.000423	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—CCR5—atopic dermatitis	4.71e-05	0.000422	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	4.66e-05	0.000418	CbGpPWpGaD
Ketamine—GRIN1—Axon guidance—IL6—atopic dermatitis	4.65e-05	0.000416	CbGpPWpGaD
Ketamine—OPRK1—GPCR ligand binding—CXCL8—atopic dermatitis	4.64e-05	0.000416	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CCL27—atopic dermatitis	4.61e-05	0.000413	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—IL2—atopic dermatitis	4.61e-05	0.000413	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—CCR3—atopic dermatitis	4.6e-05	0.000413	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	4.54e-05	0.000406	CbGpPWpGaD
Ketamine—GRIN2B—Axon guidance—IL6—atopic dermatitis	4.53e-05	0.000406	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—TAC1—atopic dermatitis	4.52e-05	0.000405	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—NPS—atopic dermatitis	4.52e-05	0.000405	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—CCR5—atopic dermatitis	4.49e-05	0.000402	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—CXCR3—atopic dermatitis	4.43e-05	0.000397	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—GLB1—atopic dermatitis	4.42e-05	0.000396	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CCL11—atopic dermatitis	4.4e-05	0.000394	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CMA1—atopic dermatitis	4.4e-05	0.000394	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—CCL5—atopic dermatitis	4.37e-05	0.000392	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—CCR5—atopic dermatitis	4.34e-05	0.000389	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—TAC1—atopic dermatitis	4.32e-05	0.000387	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—NPS—atopic dermatitis	4.32e-05	0.000387	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—CXCL10—atopic dermatitis	4.29e-05	0.000385	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CCR3—atopic dermatitis	4.25e-05	0.00038	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—ADSL—atopic dermatitis	4.24e-05	0.00038	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CXCR3—atopic dermatitis	4.23e-05	0.000379	CbGpPWpGaD
Ketamine—PTGS1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	4.22e-05	0.000378	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—IL5—atopic dermatitis	4.2e-05	0.000376	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CCL17—atopic dermatitis	4.14e-05	0.000371	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—STAT6—atopic dermatitis	4.14e-05	0.000371	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—TNF—atopic dermatitis	4.11e-05	0.000368	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—NPS—atopic dermatitis	4.1e-05	0.000368	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—TAC1—atopic dermatitis	4.1e-05	0.000368	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—CCL5—atopic dermatitis	4.07e-05	0.000365	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—CXCR3—atopic dermatitis	4.02e-05	0.000361	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—IL5—atopic dermatitis	4.01e-05	0.00036	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—TNF—atopic dermatitis	4.01e-05	0.000359	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—NFKBIA—atopic dermatitis	3.99e-05	0.000358	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—CCR5—atopic dermatitis	3.94e-05	0.000353	CbGpPWpGaD
Ketamine—OPRM1—GPCR ligand binding—CXCL8—atopic dermatitis	3.92e-05	0.000351	CbGpPWpGaD
Ketamine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	3.9e-05	0.00035	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—IL5—atopic dermatitis	3.81e-05	0.000342	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—NPS—atopic dermatitis	3.78e-05	0.000339	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—TAC1—atopic dermatitis	3.78e-05	0.000339	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—GLB1—atopic dermatitis	3.74e-05	0.000335	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CXCR3—atopic dermatitis	3.71e-05	0.000333	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—CCL5—atopic dermatitis	3.69e-05	0.000331	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—KIF3A—atopic dermatitis	3.69e-05	0.000331	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—CCR5—atopic dermatitis	3.67e-05	0.000328	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CCR3—atopic dermatitis	3.59e-05	0.000322	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—ADSL—atopic dermatitis	3.59e-05	0.000321	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—CXCL10—atopic dermatitis	3.58e-05	0.000321	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—IL5—atopic dermatitis	3.52e-05	0.000315	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CXCL10—atopic dermatitis	3.42e-05	0.000307	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CCL11—atopic dermatitis	3.34e-05	0.000299	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CMA1—atopic dermatitis	3.34e-05	0.000299	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—CCR5—atopic dermatitis	3.33e-05	0.000298	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—IL6—atopic dermatitis	3.32e-05	0.000297	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—GLB1—atopic dermatitis	3.26e-05	0.000292	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—CXCL10—atopic dermatitis	3.25e-05	0.000291	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—IL6—atopic dermatitis	3.23e-05	0.00029	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—TAC1—atopic dermatitis	3.2e-05	0.000287	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—NPS—atopic dermatitis	3.2e-05	0.000287	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	3.15e-05	0.000283	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—STAT6—atopic dermatitis	3.14e-05	0.000281	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CXCR3—atopic dermatitis	3.14e-05	0.000281	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—ADSL—atopic dermatitis	3.12e-05	0.00028	CbGpPWpGaD
Ketamine—DRD2—Circadian rythm related genes—IL6—atopic dermatitis	3.12e-05	0.00028	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—CCL5—atopic dermatitis	3.08e-05	0.000276	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—GLB1—atopic dermatitis	3.04e-05	0.000273	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CXCL10—atopic dermatitis	3e-05	0.000269	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—CXCL8—atopic dermatitis	2.99e-05	0.000268	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IL5—atopic dermatitis	2.97e-05	0.000266	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—CXCL8—atopic dermatitis	2.97e-05	0.000266	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CCL5—atopic dermatitis	2.95e-05	0.000264	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—ADSL—atopic dermatitis	2.92e-05	0.000262	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—IL2—atopic dermatitis	2.86e-05	0.000256	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—CXCL8—atopic dermatitis	2.85e-05	0.000255	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—CCL5—atopic dermatitis	2.8e-05	0.000251	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—CCR5—atopic dermatitis	2.78e-05	0.000249	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—NGF—atopic dermatitis	2.73e-05	0.000244	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	2.73e-05	0.000244	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—IL2—atopic dermatitis	2.72e-05	0.000244	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CCR3—atopic dermatitis	2.72e-05	0.000244	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—CXCL8—atopic dermatitis	2.72e-05	0.000243	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—IL6—atopic dermatitis	2.71e-05	0.000243	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CCR5—atopic dermatitis	2.65e-05	0.000238	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—CXCL8—atopic dermatitis	2.62e-05	0.000235	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—IL2—atopic dermatitis	2.6e-05	0.000233	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CCL5—atopic dermatitis	2.58e-05	0.000231	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CXCL10—atopic dermatitis	2.54e-05	0.000227	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—CCR5—atopic dermatitis	2.52e-05	0.000226	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—IL2—atopic dermatitis	2.51e-05	0.000225	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—MAPK8—atopic dermatitis	2.51e-05	0.000224	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	2.5e-05	0.000224	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—NPS—atopic dermatitis	2.42e-05	0.000217	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—TAC1—atopic dermatitis	2.42e-05	0.000217	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—NGF—atopic dermatitis	2.39e-05	0.000214	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—CXCL8—atopic dermatitis	2.38e-05	0.000213	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CXCR3—atopic dermatitis	2.38e-05	0.000213	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CCR5—atopic dermatitis	2.33e-05	0.000208	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—IL2—atopic dermatitis	2.28e-05	0.000204	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	2.26e-05	0.000202	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IL5—atopic dermatitis	2.25e-05	0.000202	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—NFKBIA—atopic dermatitis	2.25e-05	0.000202	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	2.22e-05	0.000199	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—CXCL8—atopic dermatitis	2.22e-05	0.000199	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CCL5—atopic dermatitis	2.18e-05	0.000196	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—IL2—atopic dermatitis	2.12e-05	0.00019	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—NGF—atopic dermatitis	2.02e-05	0.000181	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—CXCL8—atopic dermatitis	2.01e-05	0.00018	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GLB1—atopic dermatitis	2.01e-05	0.00018	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—NFKBIA—atopic dermatitis	1.97e-05	0.000177	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CCR5—atopic dermatitis	1.97e-05	0.000176	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ADSL—atopic dermatitis	1.92e-05	0.000172	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—IL2—atopic dermatitis	1.92e-05	0.000172	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CXCL10—atopic dermatitis	1.92e-05	0.000172	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PPARA—atopic dermatitis	1.88e-05	0.000168	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—CXCL8—atopic dermatitis	1.68e-05	0.00015	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—NFKBIA—atopic dermatitis	1.67e-05	0.000149	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CCL5—atopic dermatitis	1.65e-05	0.000148	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—IL2—atopic dermatitis	1.61e-05	0.000144	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CXCL8—atopic dermatitis	1.6e-05	0.000144	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—IL6—atopic dermatitis	1.6e-05	0.000143	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—IL2—atopic dermatitis	1.53e-05	0.000137	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—NGF—atopic dermatitis	1.53e-05	0.000137	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—IL6—atopic dermatitis	1.53e-05	0.000137	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—CXCL8—atopic dermatitis	1.53e-05	0.000137	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CCR5—atopic dermatitis	1.49e-05	0.000134	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—IL2—atopic dermatitis	1.46e-05	0.000131	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PPARA—atopic dermatitis	1.43e-05	0.000128	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MAPK8—atopic dermatitis	1.41e-05	0.000126	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CXCL8—atopic dermatitis	1.41e-05	0.000126	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—IL2—atopic dermatitis	1.34e-05	0.00012	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—IL6—atopic dermatitis	1.34e-05	0.00012	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—NFKBIA—atopic dermatitis	1.26e-05	0.000113	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MAPK8—atopic dermatitis	1.24e-05	0.000111	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PPARA—atopic dermatitis	1.21e-05	0.000109	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CXCL8—atopic dermatitis	1.19e-05	0.000107	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IL2—atopic dermatitis	1.14e-05	0.000102	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—IL6—atopic dermatitis	1.13e-05	0.000101	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PPARA—atopic dermatitis	1.06e-05	9.48e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MAPK8—atopic dermatitis	1.05e-05	9.37e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PPARA—atopic dermatitis	9.88e-06	8.85e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—IL6—atopic dermatitis	9.01e-06	8.07e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CXCL8—atopic dermatitis	9.01e-06	8.07e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IL2—atopic dermatitis	8.61e-06	7.71e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—IL6—atopic dermatitis	8.57e-06	7.68e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MAPK8—atopic dermatitis	7.93e-06	7.1e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—IL6—atopic dermatitis	7.9e-06	7.08e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IL6—atopic dermatitis	6.68e-06	5.98e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PPARA—atopic dermatitis	6.52e-06	5.84e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IL6—atopic dermatitis	5.06e-06	4.53e-05	CbGpPWpGaD
